重组疫苗降低3年心血管风险:来自多中心数据库的见解
Journal of drugs in dermatology : JDD
|December 5, 2023
概括
重组疹疫苗 (RZV) 显著降低了三年内心肌梗塞和死亡的风险. 这项研究表明,RZV疫苗接种可能为心血管和生存带来好处,需要进一步调查.
科学领域:
- 心脏病学 心脏病学
- 传染性疾病 传染性疾病
- 疫苗学 疫苗学 疫苗学
- 流行病学 流行病学
背景情况:
- 疹感染是主要心血管不良事件的已知危险因素,包括中风和心肌梗塞.
- 疫苗接种对这些心血管疾病的保护作用仍未得到充分研究.
- 这项研究调查了预防性黄疹疫苗接种在减轻心血管风险和死亡率方面的潜力.
研究的目的:
- 评估复合性疹疫苗 (RZV) 对心肌梗塞,中风和死亡率的影响.
- 为了比较与RZV与没有接种疫苗和RZV与杆菌活疫苗 (ZVL) 相关的风险.
主要方法:
- 使用TrinetX国家联合数据库进行回顾性队列分析.
- 倾向性得分匹配分析比较了接受两剂RZV的7657名患者与未接种疫苗的成年人.
- 评估三年内心肌梗塞,中风和死亡率的发生率,并进行分组分析,比较RZV和ZVL.
主要成果:
- 与未接种疫苗的人相比,接种两剂RZV的成年人表现出心肌梗塞风险降低 (aRR:0.73) 和死亡率降低 (aRR:0.70).
- 在RZV和未接种疫苗组之间没有观察到中风风险的显著差异 (aRR:0.97).
- 亚组分析表明,与接受ZVL的人相比,接受RZV的人的3年死亡风险较低 (aRR:0.84).
结论:
- 该研究得出的结论是,复合性疹疫苗 (RZV) 的使用与三年内心肌梗塞和死亡风险的显著降低有关.
- RZV可以提供对心血管事件的保护性益处,并提高生存率.
- 限制包括由于数据库对样本大小和并发症数据的限制而导致的潜在偏差.
更多相关视频
08:04Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation
Published on: July 9, 2014
15.9K
06:19Author Spotlight: A Novel Protocol for Intracameral Injections to Enhance Precision in Rodent Ophthalmology
Published on: May 31, 2024
852
相关概念视频
Psychoneuroimmunology: Cardiovascular Disease
31
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
A key area of focus in PNI is the relationship between stress and coronary...
31
Cross-reactivity
31.1K
Overview
31.1K
Cardiovascular Drugs: Classification based on Therapeutic Indications
2.9K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.9K
Ischemic Heart Disease: Overview
1.3K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.3K
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
533
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
533
Vaccinations
44.6K
Overview
44.6K
